Celltrion secures FDA's 1st interchangeable status for Rituximab biosimilar - The Korea Times
The Korea Times
·
2026.07.01
·
2026.07.01 05:39
·
👁 2
Celltrion secures FDA's 1st interchangeable status for Rituximab biosimilar The Korea Times
원문 기사 읽기
news.google.com
이 기사 공유하기